Ramdevbaba Solvent Ltd

Ramdevbaba Solvent Ltd

₹ 111 -1.03%
23 Jun - close price
About

Founded in 2008, Ramdevbaba Solvent Limited produces and distributes physically refined rice bran oil.[1]

Key Points

Business Segments
A) Third Party Manufacturing[1] The Company manufactures, distributes, markets, and sells rice bran oil to FMCG companies like Mother Dairy Fruit & Vegetable Private Limited, Marico Limited, and Empire Spices and Foods Ltd.

  • Market Cap 253 Cr.
  • Current Price 111
  • High / Low 150 / 84.5
  • Stock P/E 16.9
  • Book Value 66.3
  • Dividend Yield 0.00 %
  • ROCE 9.16 %
  • ROE 13.4 %
  • Face Value 10.0

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -2.13%
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025
346 295 392 402 527
336 283 379 388 515
Operating Profit 10 12 13 14 12
OPM % 3% 4% 3% 3% 2%
4 2 5 3 4
Interest 3 5 5 4 4
Depreciation 1 2 2 2 2
Profit before tax 10 7 10 11 9
Tax % 26% 25% 28% 26% 25%
8 6 8 8 7
EPS in Rs 166.99 10.96 4.63 3.64 3.04
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
416 576 698 686 929
403 559 679 661 903
Operating Profit 13 17 19 25 26
OPM % 3% 3% 3% 4% 3%
3 2 9 7 7
Interest 4 5 6 10 8
Depreciation 4 5 2 4 5
Profit before tax 9 9 19 18 20
Tax % 28% 28% 24% 26% 25%
6 7 15 13 15
EPS in Rs 134.51 143.67 320.25 8.04 6.56
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 17%
TTM: 35%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 31%
TTM: 15%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 10%
Return on Equity
10 Years: %
5 Years: %
3 Years: 20%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 5 5 5 16 23
Reserves 24 30 43 57 129
45 65 99 111 267
28 32 44 46 64
Total Liabilities 101 131 191 229 482
39 40 62 94 103
CWIP 0 12 28 3 189
Investments 0 0 0 8 0
62 79 101 125 191
Total Assets 101 131 191 229 482

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
12 3 11 5 -1
-13 -18 -39 -19 -128
2 15 28 14 125
Net Cash Flow 1 -1 0 -0 -3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 16 18 20 22 13
Inventory Days 39 26 29 40 36
Days Payable 20 16 19 20 14
Cash Conversion Cycle 35 28 31 41 34
Working Capital Days 30 31 30 42 50
ROCE % 17% 20% 17% 9%

Shareholding Pattern

Numbers in percentages

Apr 2024Sep 2024Mar 2025
61.09% 61.36% 59.23%
5.10% 0.37% 0.03%
5.29% 1.25% 1.21%
28.52% 37.02% 39.54%
0.00% 0.44% 0.00%
No. of Shareholders 1,7331,3371,186

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents